Vaccine Development Expertise Intravacc specializes in bridging the gap between vaccine concept and clinical trial readiness, making it an ideal partner for organizations seeking to accelerate their vaccine pipelines and reduce development risks.

Focus on Infectious Diseases The company's current priority areas include developing vaccines for gonorrhea and multiple OMV-based intranasal vaccines, presenting opportunities to collaborate with public health agencies, pharma companies, and biotech firms targeting infectious disease prevention.

Grant Funding Access With recent $633K funding from CARB-X for antibiotic-resistant bacteria vaccines, there is a clear opportunity to connect with Intravacc for innovative vaccine projects and explore co-funding or partnership possibilities.

Trusted Industry Player Recognized as one of the '5 Most Trusted Vaccine Manufacturing Companies' in 2023, Intravacc's reputation positions it as a credible partner for outsourcing vaccine development and manufacturing collaborations across the biotech sector.

Growth and Expansion As part of Utrecht Science Park Bilthoven with a dedicated team of up to 200 employees, Intravacc is expanding its research capabilities, creating potential opportunities for suppliers, equipment providers, and research collaborators to engage with a growing biotech innovator.